XML 55 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Options    
Repricing Modification (in shares) 0  
Weighted- Average Exercise Price    
Repricing Modifications (usd per share) $ 9.55  
Outstanding stock options | 2019 Omnibus Equity Incentive Plan    
Options    
Outstanding, beginning balance (in shares) 6,196,140 3,791,688
Granted (in shares) 4,175,349 1,815,314
Exercised (in shares) 0 0
Forfeited or expired (in shares) (53,166) (11,161)
Outstanding, ending balance (in shares) 10,318,323 5,595,841
Options vested and expected to vest, Ending balance (in shares) 10,318,323 5,595,841
Options exercisable, Ending balance (in shares) 3,224,039 1,888,367
Weighted- Average Exercise Price    
Outstanding, beginning balance (usd per share) $ 7.15 $ 11.33
Granted (usd per share) 1.21 1.41
Exercised (usd per share) 0 0
Forfeited or expired (usd per share) 5.25 13.29
Outstanding, ending balance (usd per share) 1.68 8.11
Options vested and expected to vest, Weighted-Average Exercise Price, Ending balance (usd per share) 1.68 8.11
Options exercisable, Weighted-Average Exercise Price, Ending balance (usd per share) $ 2.21 $ 12.66
Other Disclosures    
Outstanding, Weighted-Average Remaining Contractual Term, Ending balance 8 years 7 months 20 days 8 years 7 months 28 days
Options vested and expected to vest , Weighted-Average Remaining Contractual Term, Ending balance 8 years 7 months 20 days 8 years 7 months 28 days
Options exercisable, Weighted-Average Remaining Contractual Term, Ending balance 7 years 2 months 23 days 7 years 8 months 1 day
Outstanding, Aggregate Intrinsic Value, Ending balance $ 462,223 $ 161,428
Options vested and expected to vest , Aggregate Intrinsic Value, Ending balance 462,223 161,428
Options exercisable, Aggregate Intrinsic Value, Ending balance $ 5,500 $ 1,980